HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics
1. NRX Pharmaceuticals acquires Dura Medical, expanding their psychiatric services. 2. Dura Medical operates revenue-generating clinics for severe depression and PTSD. 3. Founder Stephen Durand aims to treat over 10,000 patients by 2026. 4. NRXP develops key therapeutics, including NRX-100 and NRX-101 for depression treatments. 5. Dura's association with Veterans Affairs enhances veteran access to psychiatric care.